CVS Faces Class Action Lawsuit For Revealing Status of 6,000 HIV Patients

According to allegations raised in a recently filed class action lawsuit, CVS accidentally revealed the HIV status involving thousands of individuals during a mailing last summer.ย 

The complaint (PDF) was filed by unidentified plaintiffs last month in the U.S. District Court for the Southern District of Ohio, against CVS Health Corporation, CareMark, LLC, and Eiserv, Inc.

Plaintiffs indicate that CVS mailed out about 6,000 letters in late July 2017 and early August 2017, notifying patients about their HIV status under contract with the Ohio Drug Assistance Program (OhDAP). The letters were mailed to participants in the program, regardless of whether they were CVS customers. However, the letters had two clear see-through “windows”, one of which revealed the patient’s HIV status.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

“This reference to the recipient’s HIV status was plainly visible through the glassine window,” the lawsuit notes. “The designation ‘HIV’ in the program identification number was not required by the Ohio Department of Health, but rather was created by CVS.”

The lawsuit seeks class action status to represent individuals who had their HIV status revealed, alleging that CVS made no effort to test or review how the letters were being mailed, since a review would have clearly shown that the identification number with “HIV” next to it was prominently visible.

The complaint notes that it is unlawful to reveal a patient’s HIV status publicly.

The class action lawsuit is almost identical to one filed against Aetna in August 2017, after the insurance company sent similar notifications to 12,000 customers through a third-party vendor.

In January, Aetna reached a $17 million settlement agreement (PDF) to resolve those cases, just months after the complaint was filed.ย The settlement also included an Immediate Relief Program paid for by Aetna, which involved up to three counseling sessions for class members and their families, and additional counseling opportunities, and reimbursements for any emergency out-of-pocket costs incurred by plaintiffs as a result of the disclosure.

The CVS class action lawsuit presents claims for unauthorized, unprivileged disclosure to a third-party of nonpublic medical information and violation of Ohio law.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Both Abbott Laboratories and Boston Scientific are fighting against a call by plaintiffs to consolidate all spinal cord stimulator lawsuits before one federal judge for pretrial proceedings.
More than 4,000 women across the U.S. have filed product liability lawsuits and medical monitoring class action claims seeking compensation for potential brain tumor symptoms and side effects allegedly caused by Depo-Provera.